glp-1 pancreatitis risk receptor agonists and the of acute pancreatitis: a living systematic review and meta-analysis incidence of pancreatitis with glp-1

Country of Origin: South Korea

Their pharmacokinetics, dosing schedules, and clinical applications differ, making individualized treatment decisions important

Key Benefits: Helps improve the look of uneven skin tone

A proteolysis-resistant MRI-visible nanoparticle formulation of GLP-1RA (nano-GLP-1RA) was engineered to target GLP-1Rexpressing cells within atherosclerotic lesions ( In ApoE/ mice, nano-GLP-1RA selectively accumulated in plaque-resident inflammatory and de-differentiated smooth muscle cells, consistent with GLP-1Rexpressing populations observed in human plaques ( Taken together, while imaging and omics technologies offer powerful tools to characterize vascular biology, their integration with GLP-1RA therapy for patient stratification remains an emerging concept that requires further clinical validation